Loading...
Cynata Therapeutics (CYYNF, $0.12) was a top loser over the last three months, falling -2 to $0.12 per share. A.I.dvisor analyzed 788 stocks in the Biotechnology Industry for the 3-month period ending August 8, 2025, and found that of them (6) exhibited an Uptrend while of them (3) demonstrated a Downtrend.
Industry Biotechnology